|
1
|
Simutis FJ, Sanderson TP, Pilcher GD, Graziano MJ. Nonclinical Safety Assessment of the γ-Secretase Inhibitor Avagacestat. Toxicol Sci 2018. [DOI: 10.1093/toxsci/kfy048] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Affiliation(s)
- Frank J Simutis
- Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903
| | - Thomas P Sanderson
- Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903
| | - Gary D Pilcher
- Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903
| | - Michael J Graziano
- Drug Safety Evaluation, Bristol-Myers Squibb Research and Development, New Brunswick, New Jersey 08903
| |
Collapse
|
|
2
|
ZHOU SHAOQIONG, FANG XIN, XIN HUAPING, GUAN SIMING. Effects of alendronate on the Notch1-RBP-Jκ signaling pathway in the osteogenic differentiation and mineralization of vascular smooth muscle cells. Mol Med Rep 2013; 8:89-94. [DOI: 10.3892/mmr.2013.1489] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/03/2013] [Accepted: 05/09/2013] [Indexed: 11/06/2022] Open
|